UBS is executing a successful integration of Credit Suisse, with 2026Q1 net income of $3.0B up 73.6% YoY, driven by a 42.3% surge in net interest income and a 58.7% fee mix.
Price trend, volume and key moving averages
Start with the evidence for owning the stock and the risks that can break the thesis.
Revenue grew to $19.5B in 2026Q1, up 42.3% YoY in NII, with net income of $3.0B (EPS $0.92) and an efficiency ratio of 50.5%, though NIM remains thin at 0.1%.
UBS is projected to achieve the fastest sequential earnings per share growth among global banks, with a 30% increase expected between 2025 and 2028. In 2025, the bank’s revenue rose 3.26% to $49.60 billion, while earnings surged 52.74% to $7.77 billion.
UBS’s Asset Management segment serves high‑net‑worth clients and has surpassed $2 trillion in invested assets, providing a solid and growing revenue stream.
The successful integration of Credit Suisse is expected to lift margins and unlock long‑term earnings power through efficiency gains, a critical test of UBS’s strategy.
Trailing total returns as of 11/7/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Oct 28, 2026 | $0.85-6.6% vs $0.91 | $13.4B+2.4% vs $13.1B |
Q3 2026 Jul 29, 2026 | $0.87-3.3% vs $0.90 | $13.3B-0.4% vs $13.4B |
Q2 2026 Apr 29, 2026 | $0.94+10.6% vs $0.85 | $13.6B+3.7% vs $13.2B |
Q1 2026 Feb 4, 2026 | $0.37-31.7% vs $0.54 | $12.2B+4.2% vs $11.7B |
PRINCETON, N.J., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that Lea Knight, chief financial officer, will present at the 2026 UBS Global Healthcare Conference on Monday, November 9, 2026, at 2:45 p.m. ET.
Wall Street tongues are wagging that the bank could finally ditch its UBS Americas unit.
NEW YORK--(BUSINESS WIRE)--UBS Investment Bank today announced coupon payments for 5 ETRACS Exchange Traded Notes traded on the NYSE Arca and expected coupon payments for 3 ETRACS Exchange Traded Notes traded on NASDAQ (together, the “ETNs”). NYSE Ticker ETN Name and Prospectus Supplementa Coupon Valuation Date Ex-Date Record Date Payment Date Coupon Amount Payment Schedule Current Yield (annualized) b HDLB ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B 10/30/2026 1.
UBS departure would be catastrophic, says Zurich cantonal government president
Benchmark UBS against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for UBS Group AG (UBS)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $47.78 | $156.61B | 15.67 | 13.72% | 18.31% | 10.67% | 1.44% | |
| $181.44 | $286.18B | 13.84 | 14.48% | 25.97% | 17.7% | 2.28% | |
| $865.82 | $260.7B | 11.76 | 8.92% | 31.81% | 17.9% | 1.92% | |
| $49.42 | $350.71B | 11.25 | 11% | 26.12% | 10.69% | 2.56% | |
| $119.05 | $204.16B | 10.51 | 5.09% | 20.8% | 9.07% | 2.42% | |
| $334.49 | $896.27B | 13.60 | 7.32% | 32.48% | 17.91% | 1.79% |
UBS Group AG (UBS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Get notified when UBS posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
UBS Group AG (UBS) stock FAQ — growth, dividends, profitability & financials explained
UBS Group AG (UBS) grew revenue by 16.0% over the trailing twelve months, compared with the twelve months before.
Yes. UBS Group AG (UBS) earned $9.65B in net income over the trailing twelve months (a 18.3% net margin).
Yes. UBS Group AG (UBS) pays a dividend that yields 1.44% at the current price, a moderate yield.
UBS Group AG (UBS) had a return on equity (ROE) of 10.7% over the trailing twelve months. That is in line with the market's typical 10-15%.
UBS Group AG (UBS) has a net interest margin (NIM) of 0.5%. NIM has been under pressure due to interest rate environment.
UBS Group AG (UBS) has an efficiency ratio of 80.2%. This is higher than peers, suggesting room for cost optimization.
